PT Darya-Varia Laboratoria Tbk (IDX:DVLA)
Indonesia · Delayed Price · Currency is IDR 1,585.00
-10.00 (-0.63%)
May 29, 2026, 4:04 PM WIB
IDX:DVLA Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,282,255 | 2,231,749 | 2,087,601 | 1,890,888 | 1,917,041 | 1,900,894 | |
Revenue Growth (YoY) | 8.70% | 6.91% | 10.40% | -1.36% | 0.85% | 3.89% |
Cost of Revenue | 1,081,801 | 1,024,313 | 995,059 | 915,648 | 910,918 | 905,125 |
Gross Profit | 1,200,454 | 1,207,436 | 1,092,543 | 975,240 | 1,006,123 | 995,768 |
Selling, General & Admin | 1,026,306 | 1,000,570 | 895,168 | 797,516 | 830,427 | 806,071 |
Other Operating Expenses | -9,815 | -8,828 | -2,404 | -11,561 | -14,269 | -5,722 |
Operating Expenses | 1,016,491 | 991,742 | 892,764 | 785,955 | 816,158 | 800,349 |
Operating Income | 183,963 | 215,694 | 199,779 | 189,284 | 189,966 | 195,419 |
Interest Expense | -24.18 | -32.36 | -51.36 | -68.28 | -171.15 | -123.47 |
Interest & Investment Income | 4,078 | 4,993 | 4,258 | 2,071 | 3,621 | 4,144 |
Currency Exchange Gain (Loss) | -995.53 | -3,256 | 907.43 | -3,098 | 6,427 | 10,892 |
EBT Excluding Unusual Items | 187,022 | 217,398 | 204,893 | 188,189 | 199,843 | 210,332 |
Gain (Loss) on Sale of Assets | 1,753 | 2,790 | 4,865 | 3,450 | 1,230 | 1,179 |
Pretax Income | 188,775 | 220,188 | 209,758 | 191,638 | 201,073 | 211,511 |
Income Tax Expense | 48,386 | 56,241 | 53,611 | 45,302 | 51,698 | 65,006 |
Earnings From Continuing Operations | 140,389 | 163,947 | 156,147 | 146,336 | 149,375 | 146,505 |
Minority Interest in Earnings | -0.69 | -0.11 | - | - | - | - |
Net Income | 140,388 | 163,947 | 156,147 | 146,336 | 149,375 | 146,505 |
Net Income to Common | 140,388 | 163,947 | 156,147 | 146,336 | 149,375 | 146,505 |
Net Income Growth | -16.20% | 5.00% | 6.70% | -2.03% | 1.96% | -9.61% |
Shares Outstanding (Basic) | 1,120 | 1,120 | 1,120 | 1,120 | 1,120 | 1,120 |
Shares Outstanding (Diluted) | 1,120 | 1,120 | 1,120 | 1,120 | 1,120 | 1,120 |
EPS (Basic) | 125.35 | 146.38 | 139.42 | 130.66 | 133.37 | 130.81 |
EPS (Diluted) | 125.35 | 146.38 | 139.42 | 130.66 | 133.37 | 130.81 |
EPS Growth | -16.20% | 5.00% | 6.70% | -2.03% | 1.96% | -9.61% |
Free Cash Flow | 179,781 | 93,856 | 229,115 | 11,270 | -74,245 | 350,220 |
Free Cash Flow Per Share | 160.52 | 83.80 | 204.57 | 10.06 | -66.29 | 312.70 |
Dividend Per Share | - | - | 110.000 | 108.000 | 119.000 | 114.000 |
Dividend Growth | - | - | 1.85% | -9.24% | 4.39% | 3.64% |
Gross Margin | 52.60% | 54.10% | 52.34% | 51.58% | 52.48% | 52.38% |
Operating Margin | 8.06% | 9.66% | 9.57% | 10.01% | 9.91% | 10.28% |
Profit Margin | 6.15% | 7.35% | 7.48% | 7.74% | 7.79% | 7.71% |
Free Cash Flow Margin | 7.88% | 4.21% | 10.97% | 0.60% | -3.87% | 18.42% |
EBITDA | 257,881 | 286,339 | 262,657 | 250,458 | 248,677 | 251,138 |
EBITDA Margin | 11.30% | 12.83% | 12.58% | 13.25% | 12.97% | 13.21% |
D&A For EBITDA | 73,918 | 70,645 | 62,879 | 61,174 | 58,712 | 55,719 |
EBIT | 183,963 | 215,694 | 199,779 | 189,284 | 189,966 | 195,419 |
EBIT Margin | 8.06% | 9.66% | 9.57% | 10.01% | 9.91% | 10.28% |
Effective Tax Rate | 25.63% | 25.54% | 25.56% | 23.64% | 25.71% | 30.73% |